Thomas Ferrante Discusses the Future of Remote Patient Monitoring
April 26, 2023
Modern Healthcare
Foley & Lardner LLP Thomas Ferrante is quoted in the Modern Healthcare article, “Remote patient monitoring poised to grow if reimbursement remains,” discussing the importance of reimbursement for the robustness of remote patient monitoring services.
On May 11, when the public health emergency ends, so too will the temporary flexibilities around remote patient monitoring that made it more cost effective for providers to implement remote services.
Ferrante explained that this will “put remote patient monitoring companies in a tight spot” and “force them to start discharging patients and living with the potential consequences of falling patient adherence rates.”
(Subscription required)
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.